BFA
RGNX icon

BlackRock Fund Advisors’s Regenxbio RGNX Stock Holding History

BlackRock Fund Advisors’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$19.2M Buy
1,034,945
+465,219
+82% +$8.89M ﹤0.01% 2209
2016
Q3 		$7.98M Buy
569,726
+53,547
+10% +$591K ﹤0.01% 2590
2016
Q2 		$4.13M Buy
516,179
+330,862
+179% +$3.67M ﹤0.01% 2911
2016
Q1 		$2M Sell
185,317
-9,804
-5% -$125K ﹤0.01% 3079
2015
Q4 		$3.24M Buy
+195,121
New +$3.87M ﹤0.01% 3021

Other funds holding RGNX

BCPEM
Bain Capital Public Equity Management Boston, Massachusetts $1.05B AUM 25.71% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return